Virion protein 26 from Kaposi's sarcoma-associated herpesvirus, DNA encoding same and uses thereof
AssigneeThe Trustees of Columbia University in the City of New York
InventorsYuan Chang, Roy A. Bohenzky, James J. Russo, Isidore S. Edelman, Patrick S. Moore
Life of this patent
Estimating the term…
Abstract
This invention provides an isolated nucleic acid molecule which encodes KSHV virion protein 26. This invention provides an isolated polypeptide molecule which encodes KSHV virion protein 26. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine and method of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.
Claims14
An isolated nucleic acid encoding Kaposi's sarcoma-associated herpesvirus virion protein 26 having the amino acid sequence as set forth in SEQ ID NO:2.
Dependencies are inferred from the claim text.